tykhr
sign in
free sign up
Qualigen Therapeutics Inc
Biotechnology
Healthcare
QLGN
388 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.76
52 week high
9.13
high
5.20
52 week low
0.00
low
4.04
growth
-51.12 %
previous Close
5.53
P/E ratio
-4
market cap
2.44 M
div yield
0
usd
Dec 2024
qoq
revenue
0.00 %
net incoming
-855.82 K
52.30 %
eps
-1.16 %
75.26 %
eps surprise
0.00 %
net profit margin
-85582300.00 %
0.00 %
operating incoming
-973.04 K
23.30 %
net change in cash
786 K
191.86 %
cash on hand
1.17 M
202.62 %
cost of revenue
0.00 %
top